Covid-19 vaccine manufacturer Oxford Biomedica enjoys soaring revenues

Oxford Biomedica, which helped manufacture the AstraZeneca Covid-19 vaccine, has enjoyed a revenue boost of more than 60 per cent, thanks to its frontline position in tackling the pandemic. The London-listed cell and gene therapy group pulled in £142.8m in the year to 31 December, up from £87.7m in 2020. Interim CEO and chair Dr [...]